XBI
SPDR S&P Biotech ETF
$140.72
▲ +0.95%
+$1.33
NYSE
SPDR S&P Biotech ETF
XBI · NYSE
$140.72
▲ +0.95% · +$1.33 today
fundamentals83 /100 vs peers
weak
Revenue CAGR (3Y)
No Revenue CAGR (3Y) data
Revenue CAGR (5Y)
No Revenue CAGR (5Y) data
Profit CAGR (3Y)
No Profit CAGR (3Y) data
Profit CAGR (5Y)
No Profit CAGR (5Y) data
Profit CAGR (10Y)
No Profit CAGR (10Y) data
Compared against sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| XBISPDR S&P Biotech ETF | $0 | — | — | 83 |
| SCHWThe Charles Schwab Corporation | $157.69B | 18.0 | +21.2% | 84 |
| NUNu Holdings Ltd. | $63.28B | 20.0 | — | 81 |
| ENVAEnova International, Inc. | $4.20B | 13.7 | +17.5% | 79 |
| MAMastercard Incorporated | $440.93B | 28.9 | +16.8% | 78 |
